Skip to main content

GE HealthCare

Fuse Oncology to Showcase GE HealthCare iRT-S!GNAL Workflow at ASTRO 2026

Fuse Oncology to Showcase GE HealthCare iRT-S!GNAL Workflow at ASTRO 2026

Boone, N.C. – September 27, 2026 -- Fuse Oncology plans to demonstrate a potential integration linking GE HealthCare's Intelligent Radiation Therapy (iRT) software to its S!GNAL charge capture platform at the ASTRO 2026 Annual Meeting, running September 27-29 in Boston at booth 2533.

Concept links radiation therapy workflow software directly to charge review

The showcased workflow would allow iRT to launch S!GNAL using existing patient information, giving radiation oncology teams a direct path from treatment coordination to targeted charge review without re-entering data across systems. The capability is described as planned for a future iRT release and is currently in development and evaluation, with no confirmed commercial availability date.

Diagnostic Imaging Market to Hit $33.2B by 2031 as AI Reshapes Scanners

Diagnostic Imaging Market to Hit $33.2B by 2031 as AI Reshapes Scanners

Sheridan, Wyo. – September 19, 2026 -- The global diagnostic imaging market will expand from $26.5 billion in 2026 to $33.2 billion by 2031, a 4.6% compound annual growth rate, according to a new study by Wissen Research.

AI moves inside the scanner, cutting exam times sharply

Deep learning reconstruction algorithms are now embedded directly into image acquisition pipelines rather than applied after scanning. GE HealthCare's Sonic DL sequence allows complex multi-sequence brain and joint MRI protocols to complete in under 15 minutes, letting hospitals raise per-scanner throughput without new capital equipment. Radiology remains the top specialty for AI device clearances, with more than 1,100 cleared by the U.S. FDA to date.